Ulipristal acetate 5mg tablets (Esmya®) for intermittent treatment of uterine fibroids.

11th November 2021

The routine commissioning of ulipristal acetate 5mg tablets (Esmya®) is accepted in Devon for up to 4 courses of intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women who have not reached menopause when uterine fibroid embolisation and/or surgical treatment options are not suitable or have failed.

Filename: Ulipristal acetate 5mg tablets (Esmya®) for intermittent treatment of uterine fibroids
Filetype: pdf
Filesize: 106.96 KB
Date uploaded: 11th November 2021
Date updated: 8th December 2022
, Download